These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 28432455)

  • 21. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
    Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
    Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors.
    Pinhal-Enfield G; Ramanathan M; Hasko G; Vogel SN; Salzman AL; Boons GJ; Leibovich SJ
    Am J Pathol; 2003 Aug; 163(2):711-21. PubMed ID: 12875990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia.
    Butchi NB; Du M; Peterson KE
    Glia; 2010 Apr; 58(6):650-64. PubMed ID: 19998480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CpG ODN1826 as a Promising Mucin1-Maltose-Binding Protein Vaccine Adjuvant Induced DC Maturation and Enhanced Antitumor Immunity.
    Jie J; Zhang Y; Zhou H; Zhai X; Zhang N; Yuan H; Ni W; Tai G
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29558459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imiquimod enhances the potency of an exogenous BM-DC based vaccine against mouse melanoma.
    Ren S; Wang Q; Zhang Y; Song Y; Dong X; Zhang W; Qin X; Liu M; Yu T
    Int Immunopharmacol; 2018 Nov; 64():69-77. PubMed ID: 30149266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of human B cell activation by TLR7 and TLR9 agonists.
    Hanten JA; Vasilakos JP; Riter CL; Neys L; Lipson KE; Alkan SS; Birmachu W
    BMC Immunol; 2008 Jul; 9():39. PubMed ID: 18652679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistical toll-like receptors activated dendritic cells induce antitumor effects against carcinoembryonic antigen-expressing colon cancer.
    Hong X; Dong T; Hu J; Yi T; Li W; Zhang Z; Lin S; Niu W
    Int J Colorectal Dis; 2013 Jan; 28(1):25-33. PubMed ID: 22777000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of toll-like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma.
    Mohamed FE; Al-Jehani RM; Minogue SS; Andreola F; Winstanley A; Olde Damink SW; Habtesion A; Malagó M; Davies N; Luong TV; Dhillon AP; Mookerjee RP; Dhar DK; Jalan R
    Liver Int; 2015 Mar; 35(3):1063-76. PubMed ID: 24990399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An oral TLR7 agonist is a potent adjuvant of DNA vaccination in transgenic mouse tumor models.
    Dharmapuri S; Aurisicchio L; Neuner P; Verdirame M; Ciliberto G; La Monica N
    Cancer Gene Ther; 2009 May; 16(5):462-72. PubMed ID: 18989354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the adjuvant effect of imiquimod and CpG ODN 1826 in chimeric DNA vaccine against Japanese encephalitis.
    Zang X; Li G; Zhu J; Dong X; Zhai Y
    Int Immunopharmacol; 2024 Oct; 140():112816. PubMed ID: 39083930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-assembly nanovaccine containing TLR7/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response.
    Zhang L; Huang J; Chen X; Pan C; He Y; Su R; Guo D; Yin S; Wang S; Zhou L; Chen J; Zheng S; Qiao Y
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34452929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential adjuvant activities of TLR7 and TLR9 agonists inversely correlate with nitric oxide and PGE2 production.
    Lee J; Martinez N; West K; Kornfeld H
    PLoS One; 2015; 10(4):e0123165. PubMed ID: 25875128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppressive effect of β,β-dimethylacryloyl alkannin on activated dendritic cells in psoriasis by the TLR7/8 pathway.
    Wang Y; Zhao J; Di T; Wang M; Ruan Z; Zhang L; Xie X; Meng Y; Lin Y; Liu X; Wang N; Li P
    Int Immunopharmacol; 2016 Nov; 40():410-418. PubMed ID: 27697724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
    Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
    J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition and promotion of tumor growth with adeno-associated virus carcinoembryonic antigen vaccine and Toll-like receptor agonists.
    Triozzi PL; Aldrich W; Ponnazhagan S
    Cancer Gene Ther; 2011 Dec; 18(12):850-8. PubMed ID: 21869824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TLR ligands in the local treatment of established intracerebral murine gliomas.
    Grauer OM; Molling JW; Bennink E; Toonen LW; Sutmuller RP; Nierkens S; Adema GJ
    J Immunol; 2008 Nov; 181(10):6720-9. PubMed ID: 18981089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of protective antigen of Bacillus anthracis as a model recombinant antigen to evaluate toll-like receptors 2, 3, 4, 7 and 9 agonists in mice using established functional antibody assays, antigen-specific antibody assays and cellular assays.
    Inglefield J; Catania J; Harris A; Hickey T; Ma Z; Minang J; Baranji K; Spangler T; Look J; Ruiz C; Lu H; Alleva D; Reece JJ; Lacy MJ
    Vaccine; 2022 Sep; 40(38):5544-5555. PubMed ID: 35773119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type I IFN-mediated synergistic activation of mouse and human DC subsets by TLR agonists.
    Kreutz M; Bakdash G; Dolen Y; Sköld AE; van Hout-Kuijer MA; de Vries IJ; Figdor CG
    Eur J Immunol; 2015 Oct; 45(10):2798-809. PubMed ID: 26255864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of Th1-polarizing dendritic cells using the TLR7/8 agonist CL075.
    Spranger S; Javorovic M; Bürdek M; Wilde S; Mosetter B; Tippmer S; Bigalke I; Geiger C; Schendel DJ; Frankenberger B
    J Immunol; 2010 Jul; 185(1):738-47. PubMed ID: 20511554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD180 Ligation Inhibits TLR7- and TLR9-Mediated Activation of Macrophages and Dendritic Cells Through the Lyn-SHP-1/2 Axis in Murine Lupus.
    Yang Y; Wang C; Cheng P; Zhang X; Li X; Hu Y; Xu F; Hong F; Dong G; Xiong H
    Front Immunol; 2018; 9():2643. PubMed ID: 30498494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.